European Medicines Agency Accepts Extension Marketing Authorisation Application for Review of Celltrion’s Remsima SC, the Subcutaneous Version of Remsima®  Press of Atlantic City

INCHEON, South Korea–(BUSINESS WIRE)–Dec 2, 2018–Celltrion, Inc. (KRX:068270) today announced that the European Medicines Agency (EMA) has …



Source link

READ  Tech review: A TV that offers amazing 4K UHD picture quality and fits your budget

LEAVE A REPLY

Please enter your comment!
Please enter your name here